Aptevo TherapeuticsAPVO
13F holders, Q2 2025 (June 30)1holders −7
1new positions
9sold out
$3.05avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Aptevo Therapeutics Inc. (APVO) in their 13F filings, down 7 from Q1 2025. 1 opened new positions and 9 sold out. The largest holder was Birchview Capital, LP ($31K).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L405
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $31K |
| Exits | 9 | $23K |
All 13F filers, Q1 2025 → Q2 2025: 10,000 shares bought and 19,629 shares sold, net −9,629 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Birchview Capital, LP | 0.03% | New | 10,000 | $31K |
"% of holder's portfolio" is APVO's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.